Our work with Merck demonstrates how technology and thoughtful collaboration can help address key scientific needs in bioanalysis, By focusing on the modern demands of bioanalytical labs, we're ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
Chimeric antigen receptor (CAR) T-cell therapies hold great promise for the treatment of both hematologic cancers and solid cancers. However, they also pose unique challenges for bioanalysis. For ...
73rd ASMS Conference on Mass Spectrometry and Allied Topics – Waters Corporation (NYSE:WAT) today announced the launch of the Xevo™ TQ Absolute XR Mass Spectrometer, the Company’s most sensitive, ...
The move to large molecules in Pharma offers unparalleled opportunities to improve human health, however with this move comes new challenges for researchers shifting to biologics. To assist scientists ...
AI and ML enhance bioanalysis by automating data processing, improving precision, and supporting regulatory compliance through real-time quality control and predictive modeling. LLMs streamline ...
Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss method validation of biomarker bioanalysis. To ...
BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click workflows and full regulatory compliance. We built BASIS 2.0 to dramatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results